Quetiapine in primary insomnia: A pilot study

Psychopharmacology

Volumn 196, Issue 2, 2008, Pages 337-338

  Wiegand, Michael H ^a   Landry, Florentina ^a   Brückner, Torsten ^a   Pohl, Corina ^a   Veselý, Zdenko ^a   Jahn, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BENZODIAZEPINE RECEPTOR; CHOLINERGIC RECEPTOR; DIBENZOTHIAZEPINE DERIVATIVE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; HISTAMINE H1 RECEPTOR AGONIST; MELPERONE; MIRTAZAPINE; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PIPAMPERONE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; TRAZODONE; TRIMIPRAMINE;

ACUTE DISEASE; CHRONIC DISEASE; DRUG DOSE INCREASE; HUMAN; INSOMNIA; LETTER; NEUROPSYCHOLOGICAL TEST; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP PARAMETERS;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PILOT PROJECTS; POLYSOMNOGRAPHY; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 38349187275     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0968-8     Document Type: Letter

References (11)

1. Baune BT, Caliskan S, Todder D (2007) Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Hum Psychopharmacol 22:1-9
2. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213
3. Calabrese JR, Keck PE, MacFadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson W, Mullen J (2005) randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162:1351-1360
4. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, Rüther E (2004) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 174:421-429
5. Endicott J, Rajagopalan K, Minkwitz M, MacFadden W, BOLDER Study Group (2007) A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I or II depression: improvements in quality of life. Int Clin Psychopharmacol 22:29-37
6. Niemann H, Köhler S, Sturm S, Willmes K, Gottland S, Saß C (1999) Der California Verbal Learning Test (CVLT): Daten zu einer autorisierten deutschen Version. Zeitschrift für Neuropsychologie 10:220-221
7. Oswald WD, Roth E (1987) Der Zahlen-Verbindungs-Test (ZVT) (2. Aufl.). Hogrefe, Göttingen
8. Sokolski KN, Brown BJ (2006) Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine. Ann Pharmacother 40:567-570
9. Todder D, Caliskan S, Baune BT (2006) Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. J Clin Psychopharmacol 26:638-642
10. Wetter TC, Brunner J, Bronisch T (2002) Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 35:109-111
11. Wiegand MH (1999) Antidepressants in the treatment of insomnia. Pharmacopsychiatry 32:219